Safer Medicines Trust

R&D

The Oxford Centre for Animal Ethics is an independent centre pioneering ethical perspectives on animals and putting them on the intellectual agenda.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.